UPMC Enterprises, the medical technology investment arm of UPMC, has purchased interest in RxAnte, a company that uses analytics to predict how patients will adhere to the medications they’re prescribed.
Read more on Pittsburgh Business Times.
Pittsburgh Business Times: UPMC Enterprises invests in prescription analytics company RxAnte
Related Resources
More Resources
01.29.20
A Roadmap to Improving Your Stars Strategy in 2020
Blog Post
Heading into 2020, we often see health plans use the same strategy to improve member adherence; however, executing a plan with unchanged tactics can result in these familiar challenges:
12.10.19
RxEffect Series Week 4: Utilizing automated reporting to maximize intervention effectiveness
Blog Post
In our final post of the series, we describe how our platform provides operational performance reporting to help maximize the overall effectiveness of your interventions. We understand plans need to streamline operational efforts to save time and valuable resources.
11.27.19
RxEffect Series Week 3: Enabling an agile and effective adherence program
Blog Post
RxEffect is your configurable workflow and reporting solution. By offering the unique opportunity to address a wide range of measures related to prescribing, medication safety, or medication adherence including triple weighted measures, SUPD, and SPC opportunities, you can focus your efforts on providing the highest quality care to patients.